Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Derosa

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Oncology Research and Treatment|May 11, 2016
Long-Term PSA Control with Repeated Stereotactic Body Radiotherapy in a Patient with Oligometastatic Castration-Resistant Prostate CancerFrancesco Pasqualetti, Paola Cocuzza, Gabriele Coraggio, et al.
Oncoimmunology|September 14, 2020
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responsesPeng Liu, Liwei Zhao, Gladys Ferrere, et al.
Critical Reviews in Oncology/Hematology|May 25, 2025
The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspectsDemi Wekking, Carolina Alves Costa Silva, Roberto Viscò, et al.
Aging|March 3, 2021
Oral administration of <i>Akkermansia muciniphila</i> elevates systemic antiaging and anticancer metabolitesClaudia Grajeda-Iglesias, Sylvère Durand, Romain Daillère, et al.
Medicine|December 16, 2014
Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single centerHassan Izzedine, Bernard Escudier, Catherine Lhomme, et al.
The Prostate|May 19, 2015
Metabolic syndrome in castration-resistant prostate cancer patients treated with abirateroneVincenza Conteduca, Orazio Caffo, Lisa Derosa, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
Annals of Translational Medicine|May 13, 2020
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based studyJin-Feng Huang, Jianfei Shen, Xiao Li, et al.
European Urology|October 14, 2016
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsMarzia Del Re, Elisa Biasco, Stefania Crucitta, et al.
Cancer|August 12, 2014
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patientsLisa Derosa, Luca Galli, Paola Orlandi, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Oncology Research and Treatment|May 11, 2016
Long-Term PSA Control with Repeated Stereotactic Body Radiotherapy in a Patient with Oligometastatic Castration-Resistant Prostate CancerFrancesco Pasqualetti, Paola Cocuzza, Gabriele Coraggio, et al.
Oncoimmunology|September 14, 2020
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responsesPeng Liu, Liwei Zhao, Gladys Ferrere, et al.
Critical Reviews in Oncology/Hematology|May 25, 2025
The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspectsDemi Wekking, Carolina Alves Costa Silva, Roberto Viscò, et al.
Aging|March 3, 2021
Oral administration of <i>Akkermansia muciniphila</i> elevates systemic antiaging and anticancer metabolitesClaudia Grajeda-Iglesias, Sylvère Durand, Romain Daillère, et al.
Medicine|December 16, 2014
Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single centerHassan Izzedine, Bernard Escudier, Catherine Lhomme, et al.
The Prostate|May 19, 2015
Metabolic syndrome in castration-resistant prostate cancer patients treated with abirateroneVincenza Conteduca, Orazio Caffo, Lisa Derosa, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
Annals of Translational Medicine|May 13, 2020
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based studyJin-Feng Huang, Jianfei Shen, Xiao Li, et al.
European Urology|October 14, 2016
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsMarzia Del Re, Elisa Biasco, Stefania Crucitta, et al.
Cancer|August 12, 2014
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patientsLisa Derosa, Luca Galli, Paola Orlandi, et al.
Pageof 11